Skip to main content
logo
Hansa Biopharma AB (publ) (STO:HNSA)
Sweden flag Sweden · Delayed Price · Currency is SEK
30.96
-1.42 (-4.39%)
Sep 4, 2025, 4:00 PM CET

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202008 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2008 - 2019
Antibody-cleaving Enzyme Technology Platform
171.32M
Log In
Log In
Log In
Log In
Upgrade
Antibody-cleaving Enzyme Technology Platform Growth
27.76%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202008 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2008 - 2019
Europe
140.24M
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
31.46%
Log In
Log In
Log In
Log In
Upgrade
North America
27.96M
Log In
Log In
Log In
Log In
Upgrade
North America Growth
1.97%
Log In
Log In
Log In
Log In
Upgrade
Sweden
3.12M
Log In
Log In
Log In
Log In
Upgrade
Sweden Growth
-
Log In
Log In
Log In
Log In
Upgrade